Sugammadex dosing challenges in pediatric neuromuscular reversal-Comments on Cates et al

Paediatr Anaesth. 2024 Apr;34(4):379-380. doi: 10.1111/pan.14821. Epub 2023 Dec 11.

Authors

Huy N Nhan¹, Rui Terada², Amir L Butt², Alberto de Armendi²

Affiliations

¹ College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
² Department of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

PMID: 38078502
DOI: 10.1111/pan.14821

No abstract available

Publication types

Letter
Comment

MeSH terms

Child
Humans
Neuromuscular Nondepolarizing Agents*
Sugammadex

Substances

Neuromuscular Nondepolarizing Agents
Sugammadex